Edition:
United States

Lannett Company Inc (LCI.N)

LCI.N on New York Stock Exchange

5.27USD
11 Dec 2018
Change (% chg)

$-0.12 (-2.23%)
Prev Close
$5.39
Open
$5.81
Day's High
$5.81
Day's Low
$5.05
Volume
517,291
Avg. Vol
349,672
52-wk High
$30.35
52-wk Low
$3.34

Latest Key Developments (Source: Significant Developments)

Lannett Q1 Loss Per Share $7.65
Wednesday, 7 Nov 2018 04:17pm EST 

Nov 7 (Reuters) - Lannett Company Inc ::LANNETT ANNOUNCES FISCAL 2019 FIRST-QUARTER FINANCIAL RESULTS; RE-AFFIRMS ADJUSTED GUIDANCE FOR FISCAL 2019.Q1 ADJUSTED EARNINGS PER SHARE $0.44.Q1 LOSS PER SHARE $7.65.Q1 SALES $155.1 MILLION VERSUS I/B/E/S VIEW $145.8 MILLION.Q1 EARNINGS PER SHARE VIEW $0.39 -- THOMSON REUTERS I/B/E/S.FINALIZED PLAN TO ACHIEVE $66 MILLION ANNUALIZED COST SAVINGS BY FISCAL 2020.PLAN TO RE-INVEST OR REDEPLOY ABOUT $33 MILLION OF COST SAVINGS BACK INTO BUSINESS.INTEND TO SELL OUR CODY LABORATORIES ACTIVE PHARMACEUTICAL INGREDIENTS BUSINESS.COST REDUCTION PLAN INCLUDES DECREASED SPENDING THROUGHOUT ORGANIZATION AND WORKFORCE REDUCTIONS.FY2019 EARNINGS PER SHARE VIEW $2.04, REVENUE VIEW $591.6 MILLION -- THOMSON REUTERS I/B/E/S.REVISED 2019 GAAP ESTIMATES TO, AMONG OTHER THINGS, INCLUDE ASSET IMPAIRMENT CHARGES OF $369 MILLION.SEES 2019 GAAP SALES $585 MILLION TO $615 MILLION.  Full Article

Lannett Announces Expanded Agreement With Strategic Alliance Partner, HEC Pharm Group
Tuesday, 6 Nov 2018 06:54am EST 

Nov 6 (Reuters) - Lannett Company Inc ::LANNETT ANNOUNCES EXPANDED AGREEMENT WITH STRATEGIC ALLIANCE PARTNER, HEC PHARM GROUP, TO DISTRIBUTE TWO FDA-APPROVED PRODUCTS.LANNETT COMPANY INC - COMPANY HAS COMMENCED LAUNCH OF CLARITHROMYCIN AND EXPECTS TO BEGIN MARKETING ENTACAPONE IN EARLY CALENDAR YEAR 2019.LANNETT COMPANY INC - FINANCIAL TERMS WERE NOT DISCLOSED..  Full Article

Lannett Engages Advisors To Evaluate Debt, Capital Structure Alternatives
Monday, 8 Oct 2018 09:31am EDT 

Oct 8 (Reuters) - Lannett Company Inc ::LANNETT ENGAGES ADVISORS TO EXPLORE AND EVALUATE DEBT AND CAPITAL STRUCTURE ALTERNATIVES.LANNETT COMPANY INC - COMPANY CONTINUES TO EXPECT TO REMAIN IN COMPLIANCE WITH ITS DEBT COVENANTS THROUGH AT LEAST END OF FISCAL 2019.LANNETT - ENGAGED AND/OR EXPANDED ROLE OF ADVISORS TO HELP IN EVALUATING ALTERNATIVES REGARDING DEBT, CAPITAL STRUCTURE.  Full Article

Lannett Reports Q3 Adjusted Earnings Per Share $0.80
Monday, 7 May 2018 04:15pm EDT 

May 7 (Reuters) - Lannett Company Inc ::LANNETT ANNOUNCES FISCAL 2018 THIRD-QUARTER FINANCIAL RESULTS.Q3 ADJUSTED EARNINGS PER SHARE $0.80.Q3 EARNINGS PER SHARE $0.33.Q3 SALES $174.4 MILLION VERSUS I/B/E/S VIEW $176.3 MILLION.Q3 EARNINGS PER SHARE VIEW $0.79 -- THOMSON REUTERS I/B/E/S.SEES FY 2018 GAAP NET SALES OF $685 MILLION TO $695 MILLION.SEES FY 2018 ADJUSTED NET SALES OF $685 MILLION TO $695 MILLION.SEES FY 2018 GAAP GROSS MARGIN OF APPROXIMATELY 42%.LANNETT COMPANY SEES FY 2018 ADJUSTED GROSS MARGIN OF APPROXIMATELY 48%.Q3 EARNINGS PER SHARE VIEW $0.79, REVENUE VIEW $176.3 MILLION -- THOMSON REUTERS I/B/E/S.FY2018 REVENUE VIEW $687.3 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Lannett Company Files For Potential Mixed Shelf Offering
Tuesday, 13 Feb 2018 05:13pm EST 

Feb 13 (Reuters) - Lannett Company Inc ::LANNETT COMPANY INC FILES FOR POTENTIAL MIXED SHELF OFFERING; SIZE NOT DISCLOSED - SEC FILING.  Full Article

Lannett Co Reports Q2 Earnings Per Share $0.37
Wednesday, 7 Feb 2018 04:15pm EST 

Feb 7 (Reuters) - Lannett Company Inc ::LANNETT ANNOUNCES FISCAL 2018 SECOND-QUARTER FINANCIAL RESULTS; REPORTS RECORD REVENUES, STRONG EARNINGS.Q2 ADJUSTED EARNINGS PER SHARE $1.06.Q2 EARNINGS PER SHARE $0.37.Q2 SALES $184.3 MILLION VERSUS $170.9 MILLION.‍SEES FISCAL 2018 CAPITAL EXPENDITURES $45 MILLION TO $55 MILLION​.SEES ‍NET SALES $680 MILLION TO $700 MILLION​ FOR 2018.SEES 2018 NON-GAAP NET SALES $680 MILLION TO $700 MILLION.Q2 EARNINGS PER SHARE VIEW $0.85, REVENUE VIEW $191.8 MILLION -- THOMSON REUTERS I/B/E/S.FY2018 REVENUE VIEW $720.9 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Lannett Appoints Timothy Crew As CEO
Thursday, 21 Dec 2017 06:54am EST 

Dec 21 (Reuters) - Lannett Company Inc ::LANNETT APPOINTS TIMOTHY C. CREW AS CEO.LANNETT COMPANY INC - TIMOTHY CREW WILL SUCCEED ARTHUR BEDROSIAN, WHO WILL CONTINUE TO SERVE AS CEO UNTIL CREW JOINS COMPANY.LANNETT COMPANY INC - BOARD NAMED TIMOTHY C. CREW AS CHIEF EXECUTIVE OFFICER, EFFECTIVE JANUARY 2, 2018.  Full Article

Lannett Reports FDA Acceptance Of 505(B)(2) NDA For Cocaine Hydrochloride Topical Solution
Friday, 1 Dec 2017 06:53am EST 

Dec 1 (Reuters) - Lannett Company Inc ::LANNETT ANNOUNCES FDA ACCEPTANCE OF 505(B)(2) NEW DRUG APPLICATION FOR COCAINE HYDROCHLORIDE TOPICAL SOLUTION, A PROPRIETARY ANESTHETIC PRODUCT.LANNETT COMPANY - ‍FDA HAS ASSIGNED A PRESCRIPTION DRUG USER FEE ACT (PDUFA) GOAL DATE OF JULY 21, 2018, TEN MONTHS FROM OFFICIAL NDA SUBMISSION DATE​.  Full Article

Lannett Announces Agreement For Authorized Generic Version Of Toprol-XL
Wednesday, 29 Nov 2017 04:47pm EST 

Nov 29 (Reuters) - Lannett Company Inc ::LANNETT ANNOUNCES AGREEMENT FOR AUTHORIZED GENERIC VERSION OF TOPROL-XL®.LANNETT COMPANY INC - FINANCIAL TERMS WERE NOT DISCLOSED..LANNETT COMPANY INC - HAS ENTERED INTO AN AGREEMENT WITH ARALEZ PHARMACEUTICALS TRADING DAC.LANNETT COMPANY - ‍AGREEMENT WITH ARALEZ PHARMACEUTICALS TRADING DAC TO BECOME EXCLUSIVE DISTRIBUTOR IN U.S. OF AUTHORIZED GENERIC VERSION OF TOPROL-XL​.LANNETT COMPANY INC - DEAL TO BECOME EXCLUSIVE DISTRIBUTOR IN U.S. OF TOPROL-XL EXTENDED RELEASE TABLETS IN 25 MG, 50 MG, 100 MG AND 200MG.  Full Article

Lannett reports solid fiscal 2018 first-quarter financial results, significantly increases fiscal 2018 guidance
Monday, 6 Nov 2017 04:15pm EST 

Nov 6 (Reuters) - Lannett Company Inc :Lannett reports solid fiscal 2018 first-quarter financial results, significantly increases fiscal 2018 guidance.Q1 adjusted earnings per share $0.60.Q1 earnings per share $0.35.Q1 earnings per share view $0.52 -- Thomson Reuters I/B/E/S.Q1 sales $155 million versus I/B/E/S view $153.6 million.Lannett Company Inc sees fiscal 2018 ‍net sales of $710 million to $720 million, up from $655 million to $665 million​.Lannett Company Inc sees fiscal 2018 ‍capital expenditures of $65 million to $75 million.Q1 revenue view $153.6 million -- Thomson Reuters I/B/E/S.FY2018 revenue view $658.6 million -- Thomson Reuters I/B/E/S.  Full Article